Link Pharma Chem Ltd. Reports Q1 FY27 Profitability

Net profit for the quarter ended June 30, 2026, stood at 31.83.
Net profit for the quarter ended June 30, 2025, was 40.19.

Reader Takeaway: Sequential profit recovery driven by other income, but year-on-year profit declines.

What just happened

Link Pharma Chem Ltd. announced a net profit of 31.83 for the quarter ended June 30, 2026. This marks a significant recovery from a net loss of 40.86 reported in the March 2026 quarter. Total income for the period was 911.73, boosted by other income which included a fair value gain of 18.47 on financial assets.

Why this matters

The company has moved back into profitability after a loss-making quarter. This sequential turnaround is a positive sign for investors. However, the net profit of 31.83 for the June 2026 quarter is lower than the 40.19 reported for the same period in the previous year (June 2025).

The backstory

In the March 2026 quarter, Link Pharma Chem Ltd. reported a net loss of 40.86. The current quarter's results show a reversal of this trend. The company's revenue from operations for the June 2026 quarter was 876.84, an increase from 658.88 in the previous quarter but lower than 781.48 in the year-ago quarter.

What changes now

Investors will be watching to see if Link Pharma Chem can sustain this profitability in the coming quarters. The reliance on fair value gains in 'Other Income' is a key point to monitor, as it can lead to profit volatility.

Risks to watch

The fair value gain of 18.47 on financial assets in Other Income is a significant factor. This gain means profitability can be sensitive to market fluctuations in financial asset values, potentially masking core operational performance.

Peer comparison

No specific peer comparison data was provided in the filing.

Context metrics (time-bound)

• June 2026 Quarter: Net Profit: 31.83, Total Income: 911.73, Revenue: 876.84
• March 2026 Quarter: Net Profit: (40.86), Total Income: 673.62, Revenue: 658.88
• June 2025 Quarter: Net Profit: 40.19, Total Income: 802.40, Revenue: 781.48

What to track next

Investors should closely track the sustainability of operational profit and the impact of 'Other Income', particularly fair value adjustments, on the company's bottom line in future quarters.